Point‐of‐care testing (POCT) in haematology has seen a significant increase in both the
spectrum of tests available and the number of tests performed annually. POCT is frequently …

Starting 90 years ago with a clinical description by Glanzmann of a bleeding disorder
associated with a defect in platelet function, technologic advances helped investigators …

The guideline writing group was selected to be representative of UK‐based medical experts.
MEDLINE was systematically searched for publications in English up to the Summer of 2010 …

Oral antiplatelet drugs are a cornerstone of modern pharmacotherapy in cardiovascular
atherothrombotic diseases. The efficacy of acetylsalicylic acid (ASA, aspirin) and clopidogrel …

This article discusses the advantages and disadvantages of methods for the measurement
of platelet function. The focus is on tests that can be used to monitor antiplatelet activity in …

Aims To examine the extent of platelet inhibition by prasugrel vs. clopidogrel in a TRITON-
TIMI 38 substudy. Methods and results TRITON-TIMI 38 randomized acute coronary …

The two most widely used antiplatelet drugs in the world are aspirin and clopidogrel.
However, some patients on aspirin and/or clopidogrel therapy do not respond appropriately …

Background Chronic kidney disease (CKD) is a common co-morbidity of patients with
atherosclerotic vascular disease, and may influence the response to antiplatelet therapy …

Background: Two point‐of‐care (POC) systems have been recently proposed as rapid tools
with which to evaluate residual platelet reactivity (RPR) in coronary artery disease (CAD) …

Objectives—Statins and fibrates are hypolipidemic drugs which decrease cardiac events in
individuals without raised levels of cholesterol. These drugs inhibit platelet function, but the …